170 related articles for article (PubMed ID: 7562756)
1. Mortality studies in systemic lupus erythematosus. Results from a single center. II. Predictor variables for mortality.
Abu-Shakra M; Urowitz MB; Gladman DD; Gough J
J Rheumatol; 1995 Jul; 22(7):1265-70. PubMed ID: 7562756
[TBL] [Abstract][Full Text] [Related]
2. Prediction of short term mortality in systemic lupus erythematosus with time dependent measures of disease activity.
Cook RJ; Gladman DD; Pericak D; Urowitz MB
J Rheumatol; 2000 Aug; 27(8):1892-5. PubMed ID: 10955329
[TBL] [Abstract][Full Text] [Related]
3. Survival analysis and prognostic indicators of systemic lupus erythematosus in Pakistani patients.
Rabbani MA; Habib HB; Islam M; Ahmad B; Majid S; Saeed W; Shah SM; Ahmad A
Lupus; 2009 Aug; 18(9):848-55. PubMed ID: 19578112
[TBL] [Abstract][Full Text] [Related]
4. Summarizing disease features over time: II. Variability measures of SLEDAI-2K.
Ibañez D; Gladman D; Urowitz M
J Rheumatol; 2007 Feb; 34(2):336-40. PubMed ID: 17183620
[TBL] [Abstract][Full Text] [Related]
5. Association of the Charlson comorbidity index with mortality in systemic lupus erythematosus.
Jönsen A; Clarke AE; Joseph L; Belisle P; Bernatsky S; Nived O; Bengtsson AA; Sturfelt G; Pineau CA
Arthritis Care Res (Hoboken); 2011 Sep; 63(9):1233-7. PubMed ID: 21618451
[TBL] [Abstract][Full Text] [Related]
6. Mortality studies in systemic lupus erythematosus. Results from a single center. I. Causes of death.
Abu-Shakra M; Urowitz MB; Gladman DD; Gough J
J Rheumatol; 1995 Jul; 22(7):1259-64. PubMed ID: 7562755
[TBL] [Abstract][Full Text] [Related]
7. Mortality risks associated with specific clinical manifestations of systemic lupus erythematosus.
Ward MM; Pyun E; Studenski S
Arch Intern Med; 1996 Jun; 156(12):1337-44. PubMed ID: 8651844
[TBL] [Abstract][Full Text] [Related]
8. Association between serum total cholesterol level and renal outcome in systemic lupus erythematosus.
Tisseverasinghe A; Lim S; Greenwood C; Urowitz M; Gladman D; Fortin PR
Arthritis Rheum; 2006 Jul; 54(7):2211-9. PubMed ID: 16802357
[TBL] [Abstract][Full Text] [Related]
9. Adjusted mean Systemic Lupus Erythematosus Disease Activity Index-2K is a predictor of outcome in SLE.
Ibañez D; Gladman DD; Urowitz MB
J Rheumatol; 2005 May; 32(5):824-7. PubMed ID: 15868616
[TBL] [Abstract][Full Text] [Related]
10. Long-term prognosis and causes of death in systemic lupus erythematosus.
Doria A; Iaccarino L; Ghirardello A; Zampieri S; Arienti S; Sarzi-Puttini P; Atzeni F; Piccoli A; Todesco S
Am J Med; 2006 Aug; 119(8):700-6. PubMed ID: 16887417
[TBL] [Abstract][Full Text] [Related]
11. Summarizing disease features over time: I. Adjusted mean SLEDAI derivation and application to an index of disease activity in lupus.
Ibañez D; Urowitz MB; Gladman DD
J Rheumatol; 2003 Sep; 30(9):1977-82. PubMed ID: 12966601
[TBL] [Abstract][Full Text] [Related]
12. Influence of the antiphospholipid syndrome in the survival of patients with systemic lupus erythematosus.
Drenkard C; Villa AR; Alarcón-Segovia D; Pérez-Vázquez ME
J Rheumatol; 1994 Jun; 21(6):1067-72. PubMed ID: 7932417
[TBL] [Abstract][Full Text] [Related]
13. Disease activity, damage and survival in Mexican patients with acute severe systemic lupus erythematosus.
Zonana-Nacach A; Yañez P; Jiménez-Balderas FJ; Camargo-Coronel A
Lupus; 2007; 16(12):997-1000. PubMed ID: 18042596
[TBL] [Abstract][Full Text] [Related]
14. Systemic lupus erythematosus disease activity index 2000.
Gladman DD; Ibañez D; Urowitz MB
J Rheumatol; 2002 Feb; 29(2):288-91. PubMed ID: 11838846
[TBL] [Abstract][Full Text] [Related]
15. The effect of menopause on disease activity in systemic lupus erythematosus.
Urowitz MB; Ibañez D; Jerome D; Gladman DD
J Rheumatol; 2006 Nov; 33(11):2192-8. PubMed ID: 16981295
[TBL] [Abstract][Full Text] [Related]
16. Damage accumulation in systemic lupus erythematosus and its relation to disease activity and mortality.
Becker-Merok A; Nossent HC
J Rheumatol; 2006 Aug; 33(8):1570-7. PubMed ID: 16845708
[TBL] [Abstract][Full Text] [Related]
17. Mortality studies in systemic lupus erythematosus. Results from a single center. III. Improved survival over 24 years.
Urowitz MB; Gladman DD; Abu-Shakra M; Farewell VT
J Rheumatol; 1997 Jun; 24(6):1061-5. PubMed ID: 9195509
[TBL] [Abstract][Full Text] [Related]
18. Systemic lupus erythematosus: mortality and survival in Argentina. A multicenter study.
Bellomio V; Spindler A; Lucero E; Berman A; Santana M; Moreno C; Hidalgo RP; Paira S; Graf C; Maldonado Cocco JA; Citera G; Arriola MS; Gómez G; Barreira JC; Messina O; Asnal C; Carrillo D; Gervilla A; García L; Máscolo M; De la Sota M D; Rosso G; Somma LF; Sosa RF; Rillo O; Caracciolo JA; Lancioni G; Gómez A
Lupus; 2000; 9(5):377-81. PubMed ID: 10878732
[TBL] [Abstract][Full Text] [Related]
19. Prognostic indicators of hospitalized patients with systemic lupus erythematosus: a large retrospective multicenter study in China.
Feng X; Zou Y; Pan W; Wang X; Wu M; Zhang M; Tao J; Zhang Y; Tan K; Li J; Chen Z; Ding X; Qian X; Da Z; Wang M; Sun L
J Rheumatol; 2011 Jul; 38(7):1289-95. PubMed ID: 21459949
[TBL] [Abstract][Full Text] [Related]
20. Incidence studies of systemic lupus erythematosus in Southern Sweden: increasing age, decreasing frequency of renal manifestations and good prognosis.
Ståhl-Hallengren C; Jönsen A; Nived O; Sturfelt G
J Rheumatol; 2000 Mar; 27(3):685-91. PubMed ID: 10743809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]